Wirtz P, Steipe B
Genzentrum der Ludwig-Maximilians-Universität, München, Germany.
Protein Sci. 1999 Nov;8(11):2245-50. doi: 10.1110/ps.8.11.2245.
The folding of immunoglobulin domains requires the formation of a conserved structural disulfide. Therefore, as a general rule, they cannot be functionally expressed in the reducing environment of the cellular cytoplasm. We have previously reported that stability engineering can lead to the cytoplasmic expression of functional immunoglobulin V(L) domains. Here we apply rational stability engineering by consensus sequence analysis to V(H) domains. Isolated V(H) domains tend to aggregate more easily than V(L) domains; they do not refold quantitatively and are generally more difficult to handle in vitro. To overcome these problems, we successfully predicted and experimentally verified several stabilizing point mutations in the V(H) domain of a designed, catalytic Fv fragment. The effect of single mutations was additive, and they could be combined in a prototype domain with significantly improved stability against chemical denaturation and a 20-fold increased half time of irreversible thermal denaturation, at physiological temperature. This stabilized, isolated V(H) domain could be expressed solubly in the reducing cellular cytoplasm of Escherichia coli, at a yield of approximately 1.2 mg/L of shake flask culture. It remains fully functional, as evidenced by the successful reconstitution of an esterolytic Fv fragment with the V(L) domain. This success provides further evidence that consensus sequence engineering is a rational, plannable route to the construction of intrabodies.
免疫球蛋白结构域的折叠需要形成保守的结构二硫键。因此,一般来说,它们无法在细胞质的还原环境中实现功能性表达。我们之前曾报道,稳定性工程可使功能性免疫球蛋白V(L)结构域在细胞质中表达。在此,我们通过共有序列分析对V(H)结构域应用合理的稳定性工程。与V(L)结构域相比,分离出的V(H)结构域更容易聚集;它们不能定量重折叠,并且在体外通常更难处理。为克服这些问题,我们成功预测并通过实验验证了设计的催化性Fv片段的V(H)结构域中的几个稳定化点突变。单个突变的效果具有加和性,并且可以在一个原型结构域中组合起来,使其对化学变性的稳定性显著提高,在生理温度下不可逆热变性的半衰期增加了20倍。这种稳定化的分离V(H)结构域能够在大肠杆菌的还原性细胞质中可溶性表达,摇瓶培养的产量约为1.2 mg/L。它仍然具有完全的功能,这通过与V(L)结构域成功重构酯解Fv片段得到证明。这一成功进一步证明共有序列工程是构建胞内抗体的一条合理、可规划的途径。